FOOT & ANKLE
Immediate-release tapentadol reduces pain vs placebo in bunionectomy in Taiwanese patients
Curr Med Res Opin. 2015 Nov;31(11):2001-960 patients between the ages of 20-80 and undergoing bunionectomy surgery were randomized to receive either instant-release oral tapentadol 50mg, instant-release oral tapentadol 75mg, or placebo postoperative pain management. The purpose of the study was to determine the efficacy and safety of tapentadol for pain management in the Taiwanese population. Results found 50mg and 75mg tapentadol to provide significantly greater pain intensity reduction and greater pain relief compared to placebo treatment. More adverse events were observed in the tapentadol groups, with dizziness, nausea, and vomiting being the most common events. No serious adverse events or deaths were observed in any treatment group.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
